|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
F
face blindness, 1995, Vol. 09(3) pp. 2; 1995, Vol. 09(4) pp. 6; 2000, Vol. 14(4) pp. 2. See also eye-gaze perception
face processing disorders, 2002, Vol. 16(4) pp. 4
face recognition in autistics, 1989, Vol. 03(4) pp. 5; 2000, Vol. 14(2) pp. 6; 2001, Vol. 15(2) pp. 2; 2004, Vol. 18(3) pp. 7.
Face to Face (Morphett), 1988, Vol. 02(3) pp. 7
facial-expression perception problems
facial expressiveness, 2001, Vol. 15(2) pp. 5; 2002, Vol. 16(2) pp. 2.
facial motor abnormalities, 1997, Vol. 11(3) pp. 1
facilitated communication
and automatic writing compared, 1999, Vol. 13(1) pp. 2
for communication deficits, 1990, Vol. 04(4) pp. 1; 1993, Vol. 07(1) pp. 6.
in courtroom, 2000, Vol. 14(2) pp. 5
evaluation of DEAL program, 1991, Vol. 05(1) pp. 1; 1991, Vol. 05(2) pp. 6.
evaluations of, 1991, Vol. 05(1) pp. 6; 1992, Vol. 06(4) pp. 2; 1993, Vol. 07(1) pp. 2; 1993, Vol. 07(2) pp. 7; 1993, Vol. 07(3) pp. 7; 1993, Vol. 07(4) pp. 7; 1994, Vol. 08(1) pp. 7; 1994, Vol. 08(2) pp. 2.
four-object method, 1993, Vol. 07(3) pp. 7
and language, 1990, Vol. 04(4) pp. 1; 1992, Vol. 06(3) pp. 3; 1992, Vol. 06(4) pp. 1; 1993, Vol. 07(2) pp. 6; 1993, Vol. 07(3) pp. 6; 1994, Vol. 08(2) pp. 2; 1994, Vol. 08(3) pp. 7.
lawsuits, 1994, Vol. 08(1) pp. 7
and literacy, 1992, Vol. 06(3) pp. 3; 1992, Vol. 06(4) pp. 6; 1993, Vol. 07(3) pp. 3; 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(1) pp. 6.
mechanical support for, 1998, Vol. 12(2) pp. 2
Ouija board effect, 1992, Vol. 06(3) pp. 1; 1994, Vol. 08(1) pp. 7.
PBS Frontline documentary on, 1993, Vol. 07(3) pp. 1
and power of suggestion, 1999, Vol. 13(1) pp. 2
and questionable messages, 1993, Vol. 07(4) pp. 6
sexual abuse allegations, 1992, Vol. 06(1) pp. 1; 1992, Vol. 06(2) pp. 6; 1994, Vol. 08(3) pp. 7.
sexual abuse court cases, 1992, Vol. 06(3) pp. 1; 1992, Vol. 06(4) pp. 3; 1993, Vol. 07(1) pp. 2; 1993, Vol. 07(2) pp. 7; 1993, Vol. 07(3) pp. 3.
success stories, 1991, Vol. 05(3) pp. 7
support groups for clients, 1993, Vol. 07(2) pp. 6; 1994, Vol. 08(1) pp. 5.
support groups for facilitators, 1993, Vol. 07(2) pp. 6; 1993, Vol. 07(4) pp. 6; 1994, Vol. 08(1) pp. 5.
and telepathy, 1999, Vol. 13(1) pp. 2
types of, 1994, Vol. 08(2) pp. 2
faded bedtime with response cost (FBRC), 1997, Vol. 11(4) pp. 6
Faden, Howard, 1994, Vol. 08(4) pp. 1
Falconi, Oscar, 1998, Vol. 12(4) pp. 7
false picture test, 1998, Vol. 12(4) pp. 6
families of autistics, 1991, Vol. 05(3) pp. 6; 1993, Vol. 07(3) pp. 5; 1995, Vol. 09(3) pp. 5; 1999, Vol. 13(1) pp. 5; 2000, Vol. 14(1) pp. 3.
autoimmune disorders in, 2003, Vol. 17(4) pp. 2
behavioral tendencies in, 1998, Vol. 12(3) pp. 2
cognitive strengths and weaknesses, 1998, Vol. 12(3) pp. 2
professions in, 1998, Vol. 12(3) pp. 2
reproductive stoppage in, 2001, Vol. 15(4) pp. 5
sibling-directed aggression interventions for, 1999, Vol. 13(1) pp. 5
studies on, 1989, Vol. 03(2) pp. 2; 1993, Vol. 07(2) pp. 2; 1999, Vol. 13(1) pp. 6.
twinning high in, 2001, Vol. 15(4) pp. 5
Families United for Intensive Autism Training (FIAT), 1998, Vol. 12(2) pp. 6
Family Forum on Autism (newsletter), 1988, Vol. 02(3) pp. 7
family studies, 1993, Vol. 07(2) pp. 6
famotidine (Pepcid). See Pepcid (famotidine)
Fankhauser, Martha, 1992, Vol. 06(3) pp. 2
Farber, Jon Matthew, 1987, Vol. 01(3) pp. 1; 1988, Vol. 02(3) pp. 2.
farms, 1990, Vol. 04(3) pp. 3; 1990, Vol. 04(4) pp. 7; 1991, Vol. 05(1) pp. 7; 1994, Vol. 08(4) pp. 7; 1995, Vol. 09(1) pp. 7; 1999, Vol. 13(2) pp. 7. See also rural alternative
Faroe Island mercury study, 2000, Vol. 14(3) pp. 2
Farr, Claire, 2002, Vol. 16(1) pp. 3
Farwell, Jacqueline, 1990, Vol. 04(1) pp. 6
FAS (fetal alcohol syndrome), 1992, Vol. 06(4) pp. 5; 1998, Vol. 12(1) pp. 5.
Fasano, Alessio, 2000, Vol. 14(2) pp. 2
Fast ForWord, 1997, Vol. 11(4) pp. 1
Fatemi, S. Hossein, 1998, Vol. 12(3) pp. 4; 2001, Vol. 15(2) pp. 1; 2003, Vol. 17(2) pp. 2.
fatty acids, 2000, Vol. 14(4) pp. 6; 2002, Vol. 16(1) pp. 4.
Fava, Giovanni A., 2003, Vol. 17(2) pp. 4
Favell, Judith, 1988, Vol. 02(4) pp. 6; 1989, Vol. 03(1) pp. 1.
Fayad, M. N., 1997, Vol. 11(1) pp. 1
FDA (Food and Drug Administration)
on antidepressants for children, 2003, Vol. 17(3) pp. 2; 2004, Vol. 18(1) pp. 2; 2004, Vol. 18(3) pp. 2.
on auditory integration training devices, 1995, Vol. 09(4) pp. 2
on autism's hopelessness, 2003, Vol. 17(2) pp. 1; 2003, Vol. 17(4) pp. 6.
on diphenhydramine compounds, 2003, Vol. 17(1) pp. 5
versus Dr. Fudenberg, 1989, Vol. 03(4) pp. 3; 1997, Vol. 11(2) pp. 1.
and drug companies, 2000, Vol. 14(3) pp. 7
on folic acid supplementation, 1992, Vol. 06(3) pp. 5
Health Freedom Act of 19 1992, Vol. 92(S) pp. ,; 1992, Vol. 06(3) pp. 2.
HR 1709, 1993, Vol. 07(2) pp. 1; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 7; 1994, Vol. 08(3) pp. 7.
HR 5746, 1992, Vol. 06(3) pp. 2
Kessler, David, 1996, Vol. 10(4) pp. 6
on medical food, 2003, Vol. 17(3) pp. 6
on mercury exposure levels, 2003, Vol. 17(2) pp. 7; 2004, Vol. 18(2) pp. 6.
"mercury-free" vaccines, 2004, Vol. 18(3) pp. 2
policing of pharmaceuticals and supplements compared, 1994, Vol. 08(1) pp. 7
raids by, 1992, Vol. 06(2) pp. 3; 1993, Vol. 07(4) pp. 7.
Regulations on Dietary Supplements, 1993, Vol. 07(4) pp. 1
Rimland's letter to, 2003, Vol. 17(2) pp. 3
S. 722, 2003, Vol. 17(3) pp. 9
SB 784, 1993, Vol. 07(2) pp. 1; 1993, Vol. 07(3) pp. 1; 1993, Vol. 07(4) pp. 7; 1994, Vol. 08(3) pp. 7.
on secretin, 1998, Vol. 12(4) pp. 3; 2001, Vol. 15(3) pp. 4.
and supplements, 1994, Vol. 08(2) pp. 1–2
on supplements, 1993, Vol. 07(3) pp. 1; 2003, Vol. 17(2) pp. 1.
on Tarvil, 2003, Vol. 17(3) pp. 6
thimerosol negligence by, 2003, Vol. 17(2) pp. 1; 2004, Vol. 18(4) pp. 2.
as thimerosol opponents, 1999, Vol. 13(3) pp. 1; 2002, Vol. 16(2) pp. 1; 2002, Vol. 16(3) pp. 3; 2003, Vol. 17(1) pp. 1.
tryptophan ban by, 1994, Vol. 08(1) pp. 3
U Series crackdown by, 1992, Vol. 06(3) pp. 2
Vaccines and Related Biological Products Advisory Committee and drug companies, 2000, Vol. 14(3) pp. 7
website, 2003, Vol. 17(2) pp. 1
FEAT (Families for Effective Autism Treatment), 1995, Vol. 09(2) pp. 3
febrile seizures, 1990, Vol. 04(1) pp. 6; 1992, Vol. 06(4) pp. 7.
feces smearing, 1991, Vol. 05(4) pp. 5; 1992, Vol. 06(3) pp. 6; 2004, Vol. 18(3) pp. 5.
feeding problems, 1994, Vol. 08(3) pp. 5; 1995, Vol. 09(4) pp. 7. See also eating disorders
Fehr, Al, 1989, Vol. 03(4) pp. 6
Fein, Deborah, 1987, Vol. 01(4) pp. 1; 1989, Vol. 03(1) pp. 2; 1997, Vol. 11(4) pp. 7.
Feinberg, E., 1998, Vol. 12(2) pp. 6
Feingold diet, 1995, Vol. 09(2) pp. 5; 1995, Vol. 09(4) pp. 6.
Feinstein, Dianne (U.S. Senator, CA), 1997, Vol. 11(2) pp. 6
felbamate (Felbatol), 1993, Vol. 07(4) pp. 5; 1994, Vol. 08(2) pp. 7; 1994, Vol. 08(3) pp. 2.
Fen-Phen. See fenfluramine (Pondimin)
fenfluramine (Pondimin)
and academic success, 1987, Vol. 01(3) pp. 2
for attention disorders, 1990, Vol. 04(2) pp. 4; 1993, Vol. 07(4) pp. 4.
and behaviors, 1987, Vol. 01(3) pp. 2
and buspirone compared, 1994, Vol. 08(3) pp. 4
cardiac problems from, 2002, Vol. 16(4) pp. 2
compensation claims for heart damage, 2002, Vol. 16(4) pp. 2
controversy on, 1987, Vol. 01(3) pp. 1; 1988, Vol. 02(4) pp. 2; 1989, Vol. 03(1) pp. 4; 1990, Vol. 04(1) pp. 2; 1990, Vol. 04(2) pp. 4.
and IQ, 1987, Vol. 01(3) pp. 2; 1988, Vol. 02(4) pp. 2.
for language disorders, 1987, Vol. 01(3) pp. 2
as neurotoxin, 1996, Vol. 10(3) pp. 4
and pulmonary hypertension, 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(1) pp. 5.
and vitamin therapies compared, 1990, Vol. 04(2) pp. 4; 1991, Vol. 05(1) pp. 3.
Fenske, Edward C., 1987, Vol. 01(1) pp. 2; 1994, Vol. 08(3) pp. 3.
Ferguson, J. N., 2001, Vol. 15(1) pp. 4
Fernald, M., 1987, Vol. 01(4) pp. 1
Fernell, E., 1997, Vol. 11(4) pp. 4
Ferring Laboratories, 1998, Vol. 12(3) pp. 3; 1998, Vol. 12(4) pp. 3; 1999, Vol. 13(3) pp. 2.
fetal alcohol syndrome (FAS), 1992, Vol. 06(4) pp. 5; 1998, Vol. 12(1) pp. 5.
fever-related seizures, 1990, Vol. 04(1) pp. 6; 1992, Vol. 06(4) pp. 7.
FGF therapy, 1997, Vol. 11(3) pp. 3
fibroblasts, 1997, Vol. 11(3) pp. 3
fidelity vs. breadth of focus, 1989, Vol. 03(1) pp. 3
Field, Tiffany, 1997, Vol. 11(3) pp. 5
Fighting for Tony (Callahan), 1989, Vol. 03(2) pp. 3
Filipek, LaVonne, 1996, Vol. 10(4) pp. 6
Filipek, P. A., 2000, Vol. 14(3) pp. 4
fillings, 2000, Vol. 14(4) pp. 3
Findling, R.L., 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(2) pp. 4; 2000, Vol. 14(2) pp. 3.
fine-motor function, 2003, Vol. 17(2) pp. 7; 2003, Vol. 17(3) pp. 5.
Finger, Stephen, 1991, Vol. 05(3) pp. 5
finger flicking, 1998, Vol. 12(3) pp. 6
finger length, 2001, Vol. 15(2) pp. 5
fingerprints, 1990, Vol. 04(2) pp. 4
Fisch, Gene S., 1987, Vol. 01(1) pp. 6
Fischinger, Peter, 1989, Vol. 03(4) pp. 2
Fischkin, Barbara, 1993, Vol. 07(1) pp. 2
fish oil, 1999, Vol. 13(1) pp. 7; 2000, Vol. 14(4) pp. 6. See also omega-3 fatty acids
Fisher, Barbara Loe, 1998, Vol. 12(1) pp. 3; 1999, Vol. 13(3) pp. 7; 2001, Vol. 15(4) pp. 1.
Fisher, Seymour, 1993, Vol. 07(4) pp. 4
Fisher, Wayne, 1987, Vol. 01(2) pp. 4
Fisman, Sandra, 1991, Vol. 05(3) pp. 7; 1997, Vol. 11(1) pp. 2; 1997, Vol. 11(2) pp. 7.
Five-Day Allergy Relief System (Mandell), 1989, Vol. 03(2) pp. 3
5-HTP, 1999, Vol. 13(1) pp. 2 See also L-5HTP
fixations. See also obsessive behaviors
Fletcher, Peter, 2000, Vol. 14(4) pp. 1
flexibility, 2002, Vol. 16(3) pp. 5; 2003, Vol. 17(1) pp. 6.
Flowers, Charles R., 1990, Vol. 04(4) pp. 7
fluoridation methods, 1998, Vol. 12(4) pp. 5
fluosilicic acid, 1998, Vol. 12(4) pp. 5
fluoxetine (Prozac)
and aggression, 1991, Vol. 05(2) pp. 4; 1995, Vol. 09(1) pp. 1; 1998, Vol. 12(2) pp. 6.
and agitation, 1998, Vol. 12(3) pp. 4; 1998, Vol. 12(4) pp. 1.
for animation, 1998, Vol. 12(4) pp. 1
and anxiety, 1998, Vol. 12(3) pp. 4; 1999, Vol. 13(2) pp. 2.
and buspirone, 1994, Vol. 08(3) pp. 4
in children, 1993, Vol. 07(3) pp. 2; 2004, Vol. 18(3) pp. 6.
and depression, 1998, Vol. 12(3) pp. 4
dosage, 1991, Vol. 05(4) pp. 1
for eye contact, 1998, Vol. 12(4) pp. 1
for fixations, 1998, Vol. 12(4) pp. 1
for Fragile X, 1995, Vol. 09(1) pp. 1–2
and hyperactivity, 1998, Vol. 12(3) pp. 4
for inappropriate speech, 1998, Vol. 12(3) pp. 4
and inositol compared, 1997, Vol. 11(2) pp. 1
for irritability, 1998, Vol. 12(3) pp. 4
for language, 1998, Vol. 12(4) pp. 1
for lethargy, 1998, Vol. 12(3) pp. 4
obsessive thoughts, 1992, Vol. 06(3) pp. 4
for OCD, 1991, Vol. 05(2) pp. 4
for perseveration, 1999, Vol. 13(2) pp. 2
for ritualistic behaviors, 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(3) pp. 4.
for self-injuring behaviors, 1993, Vol. 07(3) pp. 2
for self-stimulating behaviors, 1993, Vol. 07(3) pp. 2
for social responsiveness, 1998, Vol. 12(3) pp. 4; 1998, Vol. 12(4) pp. 1; 1999, Vol. 13(2) pp. 2.
for speech problems, 1998, Vol. 12(3) pp. 4; 1998, Vol. 12(4) pp. 1.
for stereotypies, 1991, Vol. 05(2) pp. 4; 1998, Vol. 12(3) pp. 4.
and suicide, 1990, Vol. 04(3) pp. 7; 1991, Vol. 05(4) pp. 1; 2004, Vol. 18(1) pp. 9.
for tantrums, 1991, Vol. 05(2) pp. 4; 1991, Vol. 05(4) pp. 1; 1992, Vol. 06(3) pp. 4; 1998, Vol. 12(4) pp. 1; 1999, Vol. 13(2) pp. 2.
and tardive dyskinesia, 1996, Vol. 10(4) pp. 7; 1997, Vol. 11(1) pp. 4.
for transition problems, 1998, Vol. 12(4) pp. 1
for trichotillomania, 1991, Vol. 05(4) pp. 4
and tumors, 1995, Vol. 09(1) pp. 2
withdrawal symptoms of, 1998, Vol. 12(2) pp. 6
fluvoxamine (Luvox)
and 5-HTP compared, 1999, Vol. 13(1) pp. 2
for autistic behaviors, 1995, Vol. 09(4) pp. 1
and children, 2004, Vol. 18(3) pp. 6
and gastointestinal bleeding not linked, 1999, Vol. 13(4) pp. 4
and inositol compared, 1997, Vol. 11(2) pp. 1
for language disorders, 1996, Vol. 10(4) pp. 7
and lithium, 1988, Vol. 02(1) pp. 1; 1995, Vol. 09(4) pp. 1.
and neuroleptic drugs, 1995, Vol. 09(4) pp. 1
for obsessive thoughts, 1996, Vol. 10(4) pp. 2
for OCD behaviors, 1991, Vol. 05(1) pp. 4; 1995, Vol. 09(4) pp. 1; 1997, Vol. 11(2) pp. 1.
and suicide, 2004, Vol. 18(1) pp. 9
and Tegretol, 1995, Vol. 09(4) pp. 1
FMR1 gene, 2001, Vol. 15(2) pp. 4; 2001, Vol. 15(3) pp. 4; 2001, Vol. 15(4) pp. 6.
FMRP, 2001, Vol. 15(2) pp. 4; 2001, Vol. 15(3) pp. 4; 2001, Vol. 15(4) pp. 6.
foamboard, 2004, Vol. 18(4) pp. 7
folate, 2003, Vol. 17(1) pp. 5
folic acid
for aggression, 1996, Vol. 10(4) pp. 7
for autistic children, 1987, Vol. 01(4) pp. 2; 1995, Vol. 09(1) pp. 2.
for behaviors, 1987, Vol. 01(1) pp. 6; 1987, Vol. 01(4) pp. 2.
for cardiac longevity, 1997, Vol. 11(3) pp. 3
deficiency and fragile chromosome sites, 1987, Vol. 01(1) pp. 4
and DMG, 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(3) pp. 7.
dosages, 1997, Vol. 11(4) pp. 3
for Fragile X, 1987, Vol. 01(1) pp. 4; 1989, Vol. 03(2) pp. 2; 1990, Vol. 04(1) pp. 2.
neural tube defects and deficiency of, 1989, Vol. 03(2) pp. 4; 1992, Vol. 06(3) pp. 5; 1995, Vol. 09(4) pp. 5.
for tantrums, 1993, Vol. 07(4) pp. 6; 1995, Vol. 09(2) pp. 7.
and vitamin B6, 1987, Vol. 01(1) pp. 6
folinic acid, 2004, Vol. 18(4) pp. 1
follow-through, 1996, Vol. 10(2) pp. 5
Folstein, Susan
Fombonne, Eric, 1998, Vol. 12(3) pp. 2; 2001, Vol. 15(2) pp. 1.
Fon, Edward A., 1996, Vol. 10(2) pp. 4
Fong, Pattey, 1991, Vol. 05(3) pp. 7
Food and Drug Administration. See FDA (Food and Drug Administration)
food colorings, 1995, Vol. 09(2) pp. 5; 2002, Vol. 16(4) pp. 7; 2004, Vol. 18(1) pp. 3.
food intolerances. See also brain and gut connection
and allergies compared, 1989, Vol. 03(2) pp. 3; 1992, Vol. 06(3) pp. 6; 1993, Vol. 07(3) pp. 4.
to gluten, 1994, Vol. 08() pp. 7 ( See also celiac disease)
HCL-pepsin for, 1998, Vol. 12(4) pp. 7
Lisa Lewis paper on, 1994, Vol. 08(3) pp. 7
to milk, 1992, Vol. 06(1) pp. 7; 1994, Vol. 08(3) pp. 7; 1996, Vol. 10(3) pp. 4; 1997, Vol. 11(3) pp. 3.
and peptides, 1987, Vol. 01(2) pp. 4
to phenols, 1994, Vol. 08(1) pp. 4; 1995, Vol. 09(4) pp. 6.
and rumination, 1995, Vol. 09(1) pp. 5
and seizures, 1995, Vol. 09(4) pp. 3
to sulfur compounds, 1994, Vol. 08(1) pp. 4
Food Standards Agency (U. K.), 2002, Vol. 16(4) pp. 7
forced normalization syndrome, 1999, Vol. 13(3) pp. 4
forebrain, 1990, Vol. 04(1) pp. 4
Form E-3, 1988, Vol. 02(4) pp. 3; 2000, Vol. 14(4) pp. 3.
formaldehyde, 1995, Vol. 09(1) pp. 7; 2000, Vol. 14(4) pp. 3; 2001, Vol. 15(2) pp. 1.
fornix, 1990, Vol. 04(1) pp. 4
Forsell, Christer, 1988, Vol. 02(1) pp. 1
forward-chaining technique, 1988, Vol. 02(1) pp. 5; 1994, Vol. 08(4) pp. 5.
Foster Grant sunglass factory, 1992, Vol. 06(2) pp. 1
Fotheringham, John, 1989, Vol. 03(4) pp. 5
foundations
Adriana Foundation, 1991, Vol. 05(1) pp. 7; 1992, Vol. 06(1) pp. 3.
Charlie Foundation to Help Cure Pediatric Epilepsy, 1996, Vol. 10(1) pp. 5
Epilepsy Foundation of America, 1994, Vol. 08(2) pp. 7
Georgiana Foundation (for AIT practitioners), 1992, Vol. 06(2) pp. 2
International Health Foundation, 1992, Vol. 06(3) pp. 6
New Hope Foundation, 1997, Vol. 11(3) pp. 7
"four sweets" task, 1996, Vol. 10(1) pp. 6
Fowkes, Steven, 1996, Vol. 10(2) pp. 7
Fox, Nicola S., 1995, Vol. 09(3) pp. 4
Foxx, Richard M.
Fragile X
and age, 1987, Vol. 01(1) pp. 6
arginine in, 1991, Vol. 05(2) pp. 1
and autism, 1987, Vol. 01(1) pp. 6; 1989, Vol. 03(2) pp. 2.
cancer risk lowered by, 1991, Vol. 05(4) pp. 3; 2001, Vol. 15(4) pp. 6.
causes of, 1987, Vol. 01(2) pp. 6
cerebellar defects in, 1988, Vol. 02(4) pp. 1
declining prevalence of, 1999, Vol. 13(1) pp. 6
dendrite abnormalities in, 1992, Vol. 06(2) pp. 4; 2001, Vol. 15(2) pp. 4.
depression and, 1991, Vol. 05(3) pp. 4
diagnosis, 1987, Vol. 01(1) pp. 7; 1987, Vol. 01(2) pp. 7; 1989, Vol. 03(2) pp. 2; 1991, Vol. 05(2) pp. 1; 1993, Vol. 07(2) pp. 4; 1995, Vol. 09(3) pp. 1.
eye muscle problems, 1991, Vol. 05(4) pp. 3
females with, 1989, Vol. 03(2) pp. 1; 1990, Vol. 04(1) pp. 2; 1999, Vol. 13(1) pp. 6.
genetic defects (FMR1 gene), 1995, Vol. 09(3) pp. 1; 2001, Vol. 15(2) pp. 4; 2001, Vol. 15(3) pp. 4.
genetic defects in, 1987, Vol. 01(2) pp. 4
genetic defects (trinucleotide repetitions), 2001, Vol. 15(4) pp. 6
genetic defects (X chromosome), 1991, Vol. 05(2) pp. 2
imprinting in, 1991, Vol. 05(2) pp. 2; 2001, Vol. 15(1) pp. 5.
Kennedy Institute and Johns Hopkins Research study, 1990, Vol. 04(1) pp. 6
math games for, 1990, Vol. 04(1) pp. 5
menopause in genetic carriers of, 1998, Vol. 12(3) pp. 5; 1998, Vol. 12(4) pp. 7.
and Parkinson's, 2001, Vol. 15(3) pp. 7; 2002, Vol. 16(3) pp. 4.
as PDD cause, 1999, Vol. 13(1) pp. 6
physical characteristics of, 1987, Vol. 01(1) pp. 6
Prozac for, 1995, Vol. 09(1) pp. 1
reproductive decisions, 1989, Vol. 03(2) pp. 2
Rett Syndrome and, 1987, Vol. 01(2) pp. 7
severity and gene mutation structure, 1994, Vol. 08(1) pp. 4
speech patterns compared to ADD's and Down's, 1988, Vol. 02(2) pp. 5
supplements for, 1987, Vol. 01(1) pp. 4; 1989, Vol. 03(2) pp. 2; 1990, Vol. 04(1) pp. 2; 1993, Vol. 07(1) pp. 7; 1993, Vol. 07(2) pp. 4; 1995, Vol. 09(4) pp. 3.
Francis, A. J., 2003, Vol. 17(1) pp. 4
Frea, William D., 1994, Vol. 08(1) pp. 5; 1998, Vol. 12(1) pp. 2.
free form amino acids, 2002, Vol. 16(1) pp. 7
Freedom of Information Act, 2004, Vol. 18(3) pp. 3
Freeman, John, 1992, Vol. 06(4) pp. 7; 1996, Vol. 10(1) pp. 5.
Freschi, David F., 1991, Vol. 05(3) pp. 7; 1992, Vol. 06(2) pp. 6.
Freud is Dead (ICCBR article), 1989, Vol. 03(3) pp. 3
Freund's adjuvant, 2003, Vol. 17(3) pp. 5
Friedman, Alan, 1998, Vol. 12(4) pp. 1
Friedman, B. D., 1998, Vol. 12(1) pp. 4
friends, 1998, Vol. 12(1) pp. 5; 1999, Vol. 13(4) pp. 5.
Friendship Interview, 1995, Vol. 09(4) pp. 4
Frissell, Joan, 1999, Vol. 13(2) pp. 7
Frist, William (U.S. Senator), 2004, Vol. 18(4) pp. 3
Frith, Uta, 1987, Vol. 01(4) pp. 1; 1990, Vol. 04(2) pp. 2.
Frizell, Allison, 1989, Vol. 03(4) pp. 7
Fromberg, Robert, 1988, Vol. 02(3) pp. 7
frontal cortex abnormalities
in autistics, 1988, Vol. 02(3) pp. 4; 1995, Vol. 09(3) pp. 4.
lactate in autistics' brains, 1999, Vol. 13(4) pp. 4
NAA levels, 1999, Vol. 13(4) pp. 4
and selective attention, 1990, Vol. 04(2) pp. 4
serotonin synthesis, 1997, Vol. 11(4) pp. 4; 1999, Vol. 13(3) pp. 7.
in Tourette's, 1990, Vol. 04(3) pp. 5
frontal lobe defects
and Asperger's, 1995, Vol. 09(4) pp. 5
and echolalia, 1992, Vol. 06(1) pp. 4
and executive function, 1998, Vol. 12(3) pp. 2
and seizures in autistics, 1995, Vol. 09(4) pp. 3
and theory of mind, 1995, Vol. 09(1) pp. 4; 1995, Vol. 09(3) pp. 4.
Frost, Lori, 1995, Vol. 09(3) pp. 5
frustation level, 1991, Vol. 05(1) pp. 7
Frye and Daubert rulings, 2000, Vol. 14(2) pp. 5
Frye Hearing, 1993, Vol. 07(2) pp. 7
Fudenburg, Hugh H., 1989, Vol. 03(4) pp. 1; 1990, Vol. 04(2) pp. 7; 1997, Vol. 11(2) pp. 1.
Fukui, H., 2002, Vol. 16(4) pp. 6
full inclusion. See inclusion
full spectrum light, 1999, Vol. 13(1) pp. 4
Fuller-Nordberg, Kathy, 1994, Vol. 08(2) pp. 6
functional assessment, 1994, Vol. 08(1) pp. 2
functional association, 1990, Vol. 04(2) pp. 4
functional communication, 1992, Vol. 06(1) pp. 5; 1993, Vol. 07(4) pp. 5; 1994, Vol. 08(1) pp. 2; 1996, Vol. 10(4) pp. 2; 2000, Vol. 14(4) pp. 5.
fusiform gyrus, 2000, Vol. 14(2) pp. 6; 2004, Vol. 18(3) pp. 7.
Fux, Mendel, 1997, Vol. 11(2) pp. 1
© copyright 2005, 2006 Autism Research Institute
|
|
